We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

128 hedge funds and large institutions have $1.2B invested in Immunogen Inc in 2013 Q2 according to their latest regulatory filings, with 128 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more call options, than puts

Call options by funds: $10.4M | Put options by funds: $5.82M

Holders
128
Holders Change
+128
Holders Change %
–
% of All Funds
4.16%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
128
Increased
–
Reduced
–
Closed
–
Calls
$10.4M
Puts
$5.82M
Net Calls
+$4.56M
Net Calls Change
+$4.56M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

IMGN Hedge Fund Activity: Q2 2013 in Review

128 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2013, worth a combined $1.2B.

Buyers outnumbered sellers: 128 funds opened new IMGN positions and 0 closed out — a net gain of 128 holders — while 0 added to existing stakes and 0 trimmed.

  • 128 institutional investors held Immunogen Inc (IMGN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.2B of Immunogen Inc stock for Q2 2013.
  • 128 funds opened new Immunogen Inc positions in Q2 2013 and 0 closed out, a net change of +128 holders.

Based on aggregated 13F filings for Q2 2013.